Grégoire Gessain

6PUBLICATIONS
72CO-AUTHORS
Cancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersNanomedicineHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 20, 2026
Author Correction: DC subsets and states unraveled across human juxtatumoral and malignant tissues.

Kevin Mulder, Margaux Gardet, Wan Ting Kong

|Dec 16, 2025
Author Correction: DC subsets and states unraveled across human juxtatumoral and malignant tissues.

Kevin Mulder, Margaux Gardet, Wan Ting Kong

|Dec 08, 2025
DC subsets and states unraveled across human juxtatumoral and malignant tissues.

Kevin Mulder, Margaux Gardet, Wan Ting Kong

|Aug 22, 2025
Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay.

François-Clément Bidard, Grégoire Gessain, Thomas Bachelot

|Sep 13, 2024
TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma.

Grégoire Gessain, Ahmed-Amine Anzali, Marvin Lerousseau

|Jul 26, 2024
Timing and location dictate monocyte fate and their transition to tumor-associated macrophages.

Garett Dunsmore, Wei Guo, Ziyi Li

Pageof 1